Ryan Hartman
Directeur des opérations chez EvoEndo, Inc.
Profil
Ryan Hartman is currently the Chief Operating Officer at EvoEndo, Inc. He previously worked as the Global Group Director-Marketing & LATAM at Boston Scientific Corp.
from 2017 to 2021.
Mr. Hartman received an undergraduate degree from State University of New York College at New Paltz and a graduate degree from The New School.
Postes actifs de Ryan Hartman
| Sociétés | Poste | Début |
|---|---|---|
EvoEndo, Inc.
 EvoEndo, Inc. Medical SpecialtiesHealth Technology EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023. | Directeur des opérations | 06/04/2023 |
Anciens postes connus de Ryan Hartman
| Sociétés | Poste | Fin |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/05/2021 |
Formation de Ryan Hartman
| State University of New York College at New Paltz | Undergraduate Degree |
| The New School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
EvoEndo, Inc.
EvoEndo, Inc. Medical SpecialtiesHealth Technology EvoEndo, Inc. is a medical device company that specializes in developing systems for unsedated endoscopic procedures. The company is based in Englewood, CO. The company's technology combines sterile single-use, flexible endoscopes and VR-based patient entertainment to reduce complexity, cost, and patient/provider apprehension. The company's system allows pediatric patients and adults to receive routine endoscopies without the use of general or sedation. The company was founded by Joel Friedlander, Robin Deterding, Emily DeBoer, and Jeremy Prager. Jonathan T. Hartmann has been the CEO of the company since 2023. | Health Technology |